Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.

scientific article published on July 2009

Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLINTHERA.2009.07.018
P698PubMed publication ID19695399

P50authorMaurizio RossiniQ41067734
davide gattiQ58150575
Silvano AdamiQ114314176
P2093author name stringOmbretta Viapiana
P433issue7
P921main subjectosteoporosisQ165328
postmenopausal osteoporosisQ55950294
P304page(s)1497-1510
P577publication date2009-07-01
P1433published inClinical TherapeuticsQ15716601
P1476titleOnce-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review
P478volume31

Reverse relations

cites work (P2860)
Q38075457Adherence with medications used to treat osteoporosis: behavioral insights
Q35767240Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model
Q35331699Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials
Q36056975Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review
Q42970094Ibandronate and nonvertebral fracture efficacy: results of a recent pooled analysis
Q38104738Osteoporosis treatment: why ibandronic acid?

Search more.